Altogen Biosystems has added in vivo RNAi transfection reagent, PEG-Liposome siRNA in vivo transfection kit to its in vivo delivery product line.
The reagent is also compatible for in vivo transfection of other negatively charged molecules like RNA, DNA and small proteins, and also reduces innate immune response and low cytotoxicity due to biodegradable PEG modification.
Altogen also offers custom encapsulation of target molecules into PEG-liposome in vivo transfection reagent.
The PEGylated liposome-based siRNA delivery kit is optimised for directed RNAi induction by efficient delivery of functional small RNA molecules (siRNA, shRNA, miRNA) into tissues.
The Liposome component provides in vivo siRNA protection due to efficient siRNA-liposome encapsulation.